Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2026-05-11 17:10:42 ET · period of report 2026-05-07 · accession 0001193125-26-217103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-11 17:10 | 2026-05-07 | LMAT | Ross Bridget A | Dir | M - OptEx | $48.15 | +5,044 | 8,986 | +128% | +$242.9K |
| D | 2026-05-11 17:10 | 2026-05-07 | LMAT | Ross Bridget A | Dir | S - Sale+OE | $111.10 | -5,044 | 3,942 | -56% | -$560.4K |
| DM | 2026-05-11 17:10 | 2026-05-07 | LMAT | Ross Bridget A | Dir | M - OptEx | $0.00 | -5,044 | 1,609 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | M | A | 3,444 | $48.60 | 7,386 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2026-05-07 | M | A | 1,600 | $47.19 | 8,986 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Common | Common Stock | 2026-05-07 | S | D | 5,044 | $111.10 | 3,942 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $111.00 to $111.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-05-07 | M | D | 3,444 | $0.00 | 0 | D | $48.60 · 2021-12-11 to 2026-12-11 | 3,444 Common Stock | (F3) This option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-05-07 | M | D | 1,600 | $0.00 | 1,609 | D | $47.19 · 2022-12-12 to 2027-12-12 | 1,600 Common Stock | (F3) This option is fully vested and exercisable. |